SCHEMBL22923964

SCHEMBL22923964

C=Cc1cc(F)c2cccnc2c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.55
L3MBTL1 Q9Y468 6/20 0.55
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
TDP1 Q9NUW8 5/20 0.55
ALDH1A1 P00352 5/20 0.55
LMNA P02545 4/20 0.55
MAPT P10636 4/20 0.55
IDO1 P14902 2/20 0.55
TDO2 P48775 2/20 0.55
POLB P06746 1/20 0.55
THRB P10828 1/20 0.55
PKM P14618 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
CASP6 P55212 1/20 0.55
MPI P34949 1/20 0.51
HSP90AA1 P07900 5/20 0.46
TP53 P04637 4/20 0.46
HTT P42858 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22446564 0.87 COMT (0.50) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL16207365 0.81 KDM4E (0.62) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL737088 0.79 KDM4E (0.50) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL22446563 0.77 L3MBTL1 (0.57) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL113528 0.77 KDM4E (0.72) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL113119 0.77 KDM4E (0.72) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL115570 0.77 KDM4E (0.72) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL4457883 0.77 HSP90AA1 (0.72) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL14302133 0.76 KDM4E (0.66) KDM4EL3MBTL1MEN1KMT2ATDP1
SCHEMBL7688612 0.73 KDM4E (0.60) KDM4EL3MBTL1MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024468-A1 8-HYDROXYQUINOLINE DERIVATIVES AS DIAGNOSTIC AND THERAPEUTIC AGENTS THE GENERAL HOSPITAL CORPORATION 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024468-A1 8-HYDROXYQUINOLINE DERIVATIVES AS DIAGNOSTIC AND THERAPEUTIC AGENTS KLK3, COQ8A, PARK7 KDM4E 2935/4885L3MBTL1 3167/4885MEN1 72/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.